Eight patients received brain transplants of lab-grown dopamine cells. A year later, here's exactly what the peer-reviewed data shows, and what it doesn't.
Jul 30, 2026
•
4 min read
The FDA just expanded a landmark gene therapy to children as young as 2. Here's what Casgevy actually does, and why the age expansion matters.
Jul 12, 2026
5 min read
The first person to receive stem cell therapy for Huntington's disease was treated last month. Here is exactly what we know, and what we don't.
Jul 3, 2026
A 12-person Chicago trial just put every participant off insulin. What that result means, what it doesn't, and why it matters to stem cell therapy.
Jun 19, 2026
